Beacon Pointe Advisors, LLC Fate Therapeutics Inc Transaction History

Beacon Pointe Advisors, LLC

  • $8.89 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
BUY
$17.78 - $42.39 $161,798 - $385,749
9,100 New
9,100 $226,000
Q1 2021

May 18, 2021
SELL
$72.16 - $117.4 $252,560 - $410,900
-3,500 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$38.09 - $100.95 $133,315 - $353,325
3,500 New
3,500 $318,000

Others Institutions Holding FATE

# of Institutions
167
Shares Held
108M
Call Options Held
79.2K
Put Options Held
9K
View Full List

About FATE THERAPEUTICS INC

FATE Quotes by TradingView
  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $138M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Beacon Pointe Advisors, LLC Portfolio

Follow Beacon Pointe Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Pointe Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beacon Pointe Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email